Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine

Author： Muggia Franco Diaz Isabela Peters Godefridus J

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.4, 2012-04, pp. : 403-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sapacitabine for cancer

By Liu Xiaojun Kantarjian Hagop Plunkett William

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 4, 2012-04 ,pp. : 541-555

Informa Healthcare

Access to resources Recommend Favorite

Gemcitabine: A Critical Nucleoside for Cancer Therapy

Current Medicinal Chemistry, Vol. 19, Iss. 7, 2012-03 ,pp. : 1076-1087

Bentham Science Publishers

Access to resources Recommend Favorite

1,N6-ethenoadenine and other Fluorescent Nucleobase Analogs as Substrates for Purine-Nucleoside Phosphorylases: Spectroscopic and Kinetic Studies

Current Pharmaceutical Design, Vol. 23, Iss. 45, 2018-02 ,pp. : 6948-6966

Bentham Science Publishers

Access to resources Recommend Favorite

Gemcitabine in the treatment of bladder cancer

By Ryan C.W. Vogelzang N.J.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 547-553

Informa Healthcare

Access to resources Recommend Favorite

Lipid Nucleoside Conjugates for the Treatment of Cancer

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-04 ,pp. : 1079-1089

Bentham Science Publishers

Access to resources Recommend Favorite